Published ahead of print on August 11, 2004, doi:10.1164/rccm.200405-681OC
Am. J. Respir. Crit. Care Med., Volume 170, Number 10, November 2004, 1043-1048
A more recent version of this article appeared on November 15, 2004
Submitted on June 1, 2004
Accepted on August 6, 2004
Effects of Anti-Cytokine Therapy in a Mouse Model of Chronic Asthma
Rakesh K Kumar1*, Cristan Herbert1, Dianne C Webb2, Lily Li3, and Paul S Foster4
1 Department of Pathology, University of New South Wales, Sydney, NSW, Australia,
2 Division of Molecular Biosciences, Australian National University, John Curtin School of Medical Research, Canberra, ACT, Australia,
3 Immunobiology Research, Centocor Inc., Malvern, PA, USA,
4 Division of Molecular Biosciences, Australian National University, John Curtin School of Medical Research, Canberra, ACT, Australia; Discipline of Immunology and Microbiology, University of Newcastle, Faculty of Health, Newcastle, NSW, Australia
* To whom correspondence should be addressed. E-mail: r.kumar{at}unsw.edu.au.
The relative contribution of Th2 and Th1 cytokines to the pathogenesis of lesions of chronic asthma remains poorly understood. To date, therapeutic inhibition of Th2 cytokines has proved disappointing. We used a clinically relevant model of chronic allergic asthma in mice, to compare the effects of administering neutralizing antibodies to interleukin-13, interleukin-5 and interferon- to animals with established disease. As has been observed in clinical studies, anti-interleukin-5 inhibited both inflammation and remodeling, but had no effect on airway responsiveness to methacholine. Anti-interleukin-13 effectively suppressed eosinophil recruitment and accumulation of chronic inflammatory cells in the airways. This treatment also partially suppressed changes of airway wall remodeling, including goblet cell hyperplasia/metaplasia and subepithelial fibrosis, but had limited ability to inhibit airway hyper-reactivity. In contrast, treatment with anti-interferon- markedly suppressed airway hyper-reactivity. This antibody inhibited accumulation of chronic inflammatory cells but did not affect eosinophil recruitment or changes of remodeling. We conclude that inhibition of interleukin-5 is beneficial and inhibition of interleukin-13 has considerable potential as a therapeutic strategy in chronic asthma; that interferon- may play an important role in the pathogenesis of airway hyper-reactivity; and that co-operative interaction between Th2 and Th1 cytokines contributes to the pathogenesis of the lesions of chronic asthma.
Key words: interleukin-5, interleukin-13, interferon- , bronchial hyperreactivity, airway remodeling
This article has been cited by other articles:

|
 |

|
 |
 
M. D. Smithgall, M. R. Comeau, B.-R. Park Yoon, D. Kaufman, R. Armitage, and D. E. Smith
IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells
Int. Immunol.,
August 1, 2008;
20(8):
1019 - 1030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Walsh, N. Sahu, J. Kearley, E. Benjamin, B. H. Kang, A. Humbles, and A. August
Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma
J. Exp. Med.,
June 9, 2008;
205(6):
1285 - 1292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-C. Su, M. S. Rolph, N. G. Hansbro, C. R. Mackay, and W. A. Sewell
Granulocyte-Macrophage Colony-Stimulating Factor Is Required for Bronchial Eosinophilia in a Murine Model of Allergic Airway Inflammation
J. Immunol.,
February 15, 2008;
180(4):
2600 - 2607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Tliba and Y. Amrani
Airway Smooth Muscle Cell as an Inflammatory Cell: Lessons Learned from Interferon Signaling Pathways
Proceedings of the ATS,
January 1, 2008;
5(1):
106 - 112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Pilling, D. Roife, M. Wang, S. D. Ronkainen, J. R. Crawford, E. L. Travis, and R. H. Gomer
Reduction of Bleomycin-Induced Pulmonary Fibrosis by Serum Amyloid P
J. Immunol.,
September 15, 2007;
179(6):
4035 - 4044.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Horvat, K. W. Beagley, M. A. Wade, J. A. Preston, N. G. Hansbro, D. K. Hickey, G. E. Kaiko, P. G. Gibson, P. S. Foster, and P. M. Hansbro
Neonatal Chlamydial Infection Induces Mixed T-Cell Responses That Drive Allergic Airway Disease
Am. J. Respir. Crit. Care Med.,
September 15, 2007;
176(6):
556 - 564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Lloyd and D. S. Robinson
Allergen-induced airway remodelling
Eur. Respir. J.,
May 1, 2007;
29(5):
1020 - 1032.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Karras, J. R. Crosby, M. Guha, D. Tung, D. A. Miller, W. A. Gaarde, R. S. Geary, B. P. Monia, and S. A. Gregory
Anti-Inflammatory Activity of Inhaled IL-4 Receptor-{alpha} Antisense Oligonucleotide in Mice
Am. J. Respir. Cell Mol. Biol.,
March 1, 2007;
36(3):
276 - 285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. Fulkerson, C. A. Fischetti, and M. E. Rothenberg
Eosinophils and CCR3 Regulate Interleukin-13 Transgene-Induced Pulmonary Remodeling
Am. J. Pathol.,
December 1, 2006;
169(6):
2117 - 2126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. S. Lofgren, M. R. Mazan, E. P. Ingenito, K. Lascola, M. Seavey, A. Walsh, and A. M. Hoffman
Restrained whole body plethysmography for measure of strain-specific and allergen-induced airway responsiveness in conscious mice
J Appl Physiol,
November 1, 2006;
101(5):
1495 - 1505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Siegle, N. Hansbro, C. Herbert, M. Yang, P. S. Foster, and R. K. Kumar
Airway Hyperreactivity in Exacerbation of Chronic Asthma Is Independent of Eosinophilic Inflammation
Am. J. Respir. Cell Mol. Biol.,
November 1, 2006;
35(5):
565 - 570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Meyts, P. W. Hellings, G. Hens, B. M. Vanaudenaerde, B. Verbinnen, H. Heremans, P. Matthys, D. M. Bullens, L. Overbergh, C. Mathieu, et al.
IL-12 Contributes to Allergen-Induced Airway Inflammation in Experimental Asthma
J. Immunol.,
November 1, 2006;
177(9):
6460 - 6470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Koya, K. Takeda, T. Kodama, N. Miyahara, S. Matsubara, A. Balhorn, A. Joetham, A. Dakhama, and E. W. Gelfand
RANTES (CCL5) Regulates Airway Responsiveness after Repeated Allergen Challenge
Am. J. Respir. Cell Mol. Biol.,
August 1, 2006;
35(2):
147 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Koch, M. Witzenrath, C. Reuter, M. Herma, H. Schutte, N. Suttorp, H. Collins, and S. H. E. Kaufmann
Role of Local Pulmonary IFN-{gamma} Expression in Murine Allergic Airway Inflammation
Am. J. Respir. Cell Mol. Biol.,
August 1, 2006;
35(2):
211 - 219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Careau, L.-I. Proulx, P. Pouliot, A. Spahr, V. Turmel, and E. Y. Bissonnette
Antigen sensitization modulates alveolar macrophage functions in an asthma model
Am J Physiol Lung Cell Mol Physiol,
May 1, 2006;
290(5):
L871 - L879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. N. Georas, J. Guo, U. De Fanis, and V. Casolaro
T-helper cell type-2 regulation in allergic disease
Eur. Respir. J.,
December 1, 2005;
26(6):
1119 - 1137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ozaki, Y.-i. Seki, A. Fukushima, and M. Kubo
The Control of Allergic Conjunctivitis by Suppressor of Cytokine Signaling (SOCS)3 and SOCS5 in a Murine Model
J. Immunol.,
October 15, 2005;
175(8):
5489 - 5497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Weigt, C. Nassenstein, T. Tschernig, P. F. Muhlradt, N. Krug, and A. Braun
Efficacy of Macrophage-activating Lipopeptide-2 Combined with Interferon-{gamma} in a Murine Asthma Model
Am. J. Respir. Crit. Care Med.,
September 1, 2005;
172(5):
566 - 572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Sly, D. J. Turner, R. A. Collins, and Z. Hantos
Penh Is Not a Validated Technique for Measuring Airway Function in Mice
Am. J. Respir. Crit. Care Med.,
July 15, 2005;
172(2):
256 - 256.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Schwartzbaum, A. Ahlbom, B. Malmer, S. Lonn, A. J. Brookes, H. Doss, W. Debinski, R. Henriksson, and M. Feychting
Polymorphisms Associated with Asthma Are Inversely Related to Glioblastoma Multiforme
Cancer Res.,
July 15, 2005;
65(14):
6459 - 6465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Mimura, Y. Shinozaki, H. Kawasaki, and H. Iwamura
JTP-27536 [(+)-1,3-Dihydroxy-2-hydroxymethylpropyl-2-ammonium 2-[(R)-3-Cyclo-hexyl-1-phenylpropyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylate Monohydrate], a Novel Inhibitor of Immunoglobulins and Interleukin-5 with Anti-Inflammatory Properties in Mouse Allergic Dermatitis Model
J. Pharmacol. Exp. Ther.,
July 1, 2005;
314(1):
293 - 301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham
Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004
Am. J. Respir. Crit. Care Med.,
April 1, 2005;
171(7):
686 - 698.
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society
|
|
|